Combined Noninvasive Respiratory Support Therapies to Treat COVID-19.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Colaianni-Alfonso, N
  • Montiel, G
  • Castro-Sayat, M
  • Siroti, C
  • Laura Vega, Maria
  • Toledo, A
  • Haedo, S
  • Previgliano, I

Grupos

Abstract

The roles of high-flow nasal cannula (HFNC) and CPAP in coronavirus disease 2019 (COVID-19) are controversial. The objective of the study was to evaluate the impact of the application of a noninvasive respiratory support algorithm on clinical outcomes in subjects with COVID-19 and with acute respiratory failure.

Datos de la publicación

ISSN/ISSNe:
0020-1324, 1943-3654

RESPIRATORY CARE  DAEDALUS ENTERPRISES INC

Tipo:
Article
Páginas:
1831-1839
PubMed:
34290078
Factor de Impacto:
0,670 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 18

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19, SARS-CoV-2, combined therapy, continuous positive airway pressure, high-flow nasal cannula, hypoxemic respiratory failure

Cita

Compartir